Iovance Biotherapeutics, Inc.

Contributing Author

Recent Articles by Iovance Biotherapeutics, Inc.

May-22	Iovance Announces Five-year Results of Amtagvi (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting IOVA GlobeNewswire
May-16	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) IOVA GlobeNewswire
May-08	Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025 IOVA GlobeNewswire
May-02	Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025 IOVA GlobeNewswire